Emerging evidence suggests low Hb levels may play a significant role in the development and progression of CAD, potentially through mechanisms such as tissue hypoxia, increased cardiac output, left ventricular hypertrophy, inflammation and oxidative stress, and endothelial dysfunction. This evidence concerns the gene GSTM1 and coronary artery disorder.